Successful therapy of a newborn with Stenotrophomonas maltophilia nosocomial pneumonia with cefiderocol

被引：0
|
作者：
Trauth, Janina [1 ]
Schuler, Rahel [2 ]
Waitz, Markus [2 ]
Ehrhardt, Harald [2 ,4 ]
Fritzenwanker, Moritz [3 ]
Herold, Susanne [1 ]
机构：
[1] Justus Liebig Univ, Dept Med Internal Med Infect Dis & Infect Control, Giessen, Germany
[2] Justus Liebig Univ, Dept Gen Pediat & Neonatol, Giessen, Germany
[3] Justus Liebig Univ Giessen, Inst Med Microbiol, Giessen, Germany
[4] Univ Med Ctr Ulm, Dept Pediat & Adolescent Med, Div Neonatol & Pediat Intens Care Med, Ulm, Germany
来源：
INFECTION | 2024年
关键词：
Multi drug resistance; Stenotrophomonas maltophilia; Cefiderocol; Pneumogenic sepsis; Neonate;
D O I：
10.1007/s15010-024-02404-9
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Cefiderocol is a new siderophore-beta-lactam antibiotic used for the treatment of severe multidrug-resistant infections like sepsis, hospital-acquired and ventilator-associated pneumonia in adults, but there are only single reports on its use in the neonatal population. We describe the successful cefiderocol treatment of a newborn with pneumogenic sepsis due to Stenotrophomonas maltophilia.
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Stenotrophomonas maltophilia pneumonia in a premature infant
    Özkan, H
    Pasaoglu, G
    Olgaç, N
    Günel, R
    Yüce, A
    Gülay, Z
    TURKISH JOURNAL OF PEDIATRICS, 1999, 41 (02) : 283 - 286
  • [22] Clinical Importance of Stenotrophomonas maltophilia Nosocomial Pneumonia Due to its High Mortality in Hemodialysis Patients
    Wakino, Shu
    Imai, Eiko
    Yoshioka, Kyoko
    Kamayachi, Tadashi
    Minakuchi, Hitoshi
    Hayashi, Koichi
    Inamoto, Hajime
    Itoh, Hiroshi
    THERAPEUTIC APHERESIS AND DIALYSIS, 2009, 13 (03) : 193 - 198
  • [23] Efficacy of combination therapy versus monotherapy in the treatment of Stenotrophomonas maltophilia pneumonia
    Shah, Megan D.
    Coe, Kelci E.
    El Boghdadly, Zeinab
    Wardlow, Lynn C.
    Dela-Pena, Jennifer C.
    Stevenson, Kurt B.
    Reed, Erica E.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2019, 74 (07) : 2055 - 2059
  • [24] Transferable antibiotic resistance in nosocomial Stenotrophomonas maltophilia strain
    Blahova, J
    Kralikova, K
    Krcmery, V
    Torsova, V
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1997, 29 (03) : 129 - 132
  • [25] DIVERSITY OF NOSOCOMIAL XANTHOMONAS-MALTOPHILIA (STENOTROPHOMONAS-MALTOPHILIA) AS DETERMINED BY RIBOTYPING
    GERNERSMIDT, P
    BRUUN, B
    ARPI, M
    SCHMIDT, J
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1995, 14 (02) : 137 - 140
  • [26] Optimizing therapy for Stenotrophomonas maltophilia
    Muder, Robert R.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2007, 28 (06) : 672 - 677
  • [27] Evolution of cefiderocol resistance in Stenotrophomonas maltophilia using in vitro serial passage techniques
    Werth, Brian J.
    Ashford, Nathaniel K.
    Penewit, Kelsi
    Waalkes, Adam
    Holmes, Elizabeth A.
    Bryan, Andrew
    Salipante, Stephen J.
    JAC-ANTIMICROBIAL RESISTANCE, 2021, 4 (01):
  • [28] PREVALENCE OF NOSOCOMIAL STENOTROPHOMONAS MALTOPHILIA INFECTIONS IN ASSIUT UNIVERSITY HOSPITALS
    Thabit, Amany Gamal
    Deaf, Enas Abd-El-Meged
    Elsherbiny, Nahla Mohammad
    Wageah, Ehsan Mohammad
    BULLETIN OF PHARMACEUTICAL SCIENCES, 2014, 37 : 27 - 32
  • [29] Stenotrophomonas (Xanthomonas) maltophilia: A multidrug-resistant nosocomial pathogen
    Penzak, SR
    Abate, BJ
    PHARMACOTHERAPY, 1997, 17 (02): : 293 - 301
  • [30] Risk factors for late-onset nosocomial pneumonia caused by Stenotrophomonas maltophilia in critically ill trauma patients
    Hanes, SD
    Demirkan, K
    Tolley, E
    Boucher, BA
    Croce, MA
    Wood, GC
    Fabian, TC
    CLINICAL INFECTIOUS DISEASES, 2002, 35 (03) : 228 - 235
12345